• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

降低甘油三酯的药物。

Triglyceride-lowering agents.

机构信息

Vorozhtsov Institute of Organic Chemistry, Siberian Division, Russian Academy of Sciences, pr. akademika Lavrent'eva 9, Novosibirsk 630090, Russian Federation; Novosibirsk State University, Pirogova str. 2, Novosibirsk 630090, Russian Federation.

Vorozhtsov Institute of Organic Chemistry, Siberian Division, Russian Academy of Sciences, pr. akademika Lavrent'eva 9, Novosibirsk 630090, Russian Federation.

出版信息

Bioorg Med Chem. 2014 Jul 15;22(14):3551-64. doi: 10.1016/j.bmc.2014.05.008. Epub 2014 May 13.

DOI:10.1016/j.bmc.2014.05.008
PMID:24894768
Abstract

This review is the first attempt at systematization of the literature data on the structures and activities of triglyceride-lowering agents which used in medical practice or are in development. The effects and mechanisms of action of statins, squalene synthase inhibitors, fibrates, PPARα and PPARα/γ agonists, nicotinic acid, omega-3 fatty acids and some other molecular targets were considered. Unfortunately, to date, harmless and effective triglyceride-lowering drug still does not exist and there is still need for development of better triglyceride-lowering agents.

摘要

这篇综述首次对临床上使用或正在开发的具有降甘油三酯作用的药物的结构和活性的文献数据进行了系统的整理。文中讨论了他汀类药物、角鲨烯合酶抑制剂、贝特类药物、过氧化物酶体增殖物激活受体α和γ激动剂、烟酸、ω-3 脂肪酸和其他一些分子靶点的作用和作用机制。不幸的是,迄今为止,还没有一种安全有效的降甘油三酯药物,仍然需要开发更好的降甘油三酯药物。

相似文献

1
Triglyceride-lowering agents.降低甘油三酯的药物。
Bioorg Med Chem. 2014 Jul 15;22(14):3551-64. doi: 10.1016/j.bmc.2014.05.008. Epub 2014 May 13.
2
Hypercholesterolemia: chemical aspect of approach.高胆固醇血症:方法的化学方面。
Curr Med Chem. 2011;18(26):4076-105. doi: 10.2174/092986711796957248.
3
YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species.新型角鲨烯合酶抑制剂YM-53601可降低多种动物的血浆胆固醇和甘油三酯水平。
Br J Pharmacol. 2000 Sep;131(1):63-70. doi: 10.1038/sj.bjp.0703545.
4
Lipid-lowering properties of TAK-475, a squalene synthase inhibitor, in vivo and in vitro.角鲨烯合酶抑制剂TAK-475在体内和体外的降脂特性
Br J Pharmacol. 2003 Jul;139(5):911-8. doi: 10.1038/sj.bjp.0705332.
5
The treatment of dyslipidemia--what's left in the pipeline?血脂异常的治疗——后续还有哪些在研项目?
ChemMedChem. 2008 Feb;3(2):206-21. doi: 10.1002/cmdc.200700165.
6
Evolution of peroxisome proliferator-activated receptor agonists.过氧化物酶体增殖物激活受体激动剂的演变
Ann Pharmacother. 2007 Jun;41(6):973-83. doi: 10.1345/aph.1K013. Epub 2007 May 22.
7
Cross-talk between statins and PPARalpha in cardiovascular diseases: clinical evidence and basic mechanisms.他汀类药物与过氧化物酶体增殖物激活受体α在心血管疾病中的相互作用:临床证据与基本机制
Trends Cardiovasc Med. 2008 Apr;18(3):73-8. doi: 10.1016/j.tcm.2008.01.001.
8
Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?他汀类药物、贝特类药物、烟酸、胆固醇吸收抑制剂、阴离子交换树脂、ω-3 脂肪酸:哪些药物适合哪些患者?
Fundam Clin Pharmacol. 2009 Dec;23(6):687-92. doi: 10.1111/j.1472-8206.2009.00745.x. Epub 2009 Aug 14.
9
Statins and diabetes.他汀类药物与糖尿病
Semin Vasc Med. 2004 Nov;4(4):321-32. doi: 10.1055/s-2004-869589.
10
Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.处方ω-3脂肪酸在高甘油三酯血症治疗中的作用。
Pharmacotherapy. 2007 May;27(5):715-28. doi: 10.1592/phco.27.5.715.

引用本文的文献

1
Abnormalities of lipid metabolism in the progression and treatment of depression.抑郁症进展与治疗中的脂质代谢异常
Front Psychiatry. 2025 May 29;16:1589663. doi: 10.3389/fpsyt.2025.1589663. eCollection 2025.
2
Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer's Disease?棕藻脂类提取物对肝 X 受体和过氧化物酶体增殖物激活受体的激活作用:在阿尔茨海默病中的潜在应用?
Nutrients. 2023 Jun 30;15(13):3004. doi: 10.3390/nu15133004.
3
Clinically Relevant Dose of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor α Modulator (SPPARMα), Lowers Serum Triglyceride Levels by Targeting Hepatic PPARα in Mice.
新型选择性过氧化物酶体增殖物激活受体α调节剂(SPPARMα)匹伐贝特的临床相关剂量通过靶向小鼠肝脏中的PPARα降低血清甘油三酯水平。
Biomedicines. 2022 Jul 11;10(7):1667. doi: 10.3390/biomedicines10071667.
4
Effects of fatty acids on T cell function: role in atherosclerosis.脂肪酸对 T 细胞功能的影响:在动脉粥样硬化中的作用。
Nat Rev Cardiol. 2021 Dec;18(12):824-837. doi: 10.1038/s41569-021-00582-9. Epub 2021 Jul 12.
5
Bioactive Compounds for the Management of Hypertriglyceridemia: Evidence From Clinical Trials and Putative Action Targets.用于治疗高甘油三酯血症的生物活性化合物:来自临床试验的证据及假定作用靶点
Front Nutr. 2020 Nov 30;7:586178. doi: 10.3389/fnut.2020.586178. eCollection 2020.
6
Effects of two therapeutic dietary regimens on primary chylomicronemia in paediatric age: a retrospective data analysis.两种治疗性饮食方案对儿童原发性乳糜微粒血症的影响:一项回顾性数据分析。
Eur J Clin Nutr. 2016 Oct;70(10):1127-1131. doi: 10.1038/ejcn.2016.70. Epub 2016 May 18.
7
Man shall not live by bread alone.人活着不是单靠食物。
Nutrition. 2015 Jan;31(1):244-7. doi: 10.1016/j.nut.2014.10.002. Epub 2014 Oct 24.